Financial Synergies Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The firm bought 5,262 shares of the healthcare conglomerate’s stock, valued at approximately $1,641,000.
Several other hedge funds have also modified their holdings of UNH. Citizens National Bank Trust Department lifted its stake in UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after acquiring an additional 170 shares in the last quarter. Caitlin John LLC lifted its stake in UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after acquiring an additional 111 shares in the last quarter. Triumph Capital Management purchased a new stake in UnitedHealth Group in the 2nd quarter worth about $1,324,000. Wealth Effects LLC lifted its stake in UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after acquiring an additional 591 shares in the last quarter. Finally, Arlington Partners LLC acquired a new position in UnitedHealth Group in the 2nd quarter worth about $2,229,000. 87.86% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several research analysts have weighed in on the company. Barclays upped their target price on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. KeyCorp upped their target price on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Zacks Research raised UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Jefferies Financial Group upped their target price on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research report on Friday. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a report on Wednesday, October 8th. Eighteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Hold” and an average target price of $385.13.
UnitedHealth Group Stock Performance
Shares of NYSE UNH opened at $356.53 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market cap of $322.90 billion, a price-to-earnings ratio of 15.45, a P/E/G ratio of 2.31 and a beta of 0.47. The business’s 50-day simple moving average is $329.38 and its 200-day simple moving average is $343.62. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same period last year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- Manufacturing Stocks Investing
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- How to Use the MarketBeat Stock Screener
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- The 3 Best Blue-Chip Stocks to Buy Now
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.